EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Sodium Transport Reveals CHP1 Downregulation as a Novel Molecular Feature of Malignant Progression in Clear Cell Renal Cell Carcinoma: Insights from Integrated Multi-Omics Analyses

Yun Wu, Ri-Ting Zhu iD, Jia-Ru Chen, Xiao-Min Liu, Guo-Liang Huang, Jin-Cheng Zeng iD, Hong-Bing Yu, Xin Liu, Cui-Fang Han iD

Biomolecules · 2025

DOI: 10.3390/biom15071019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Yun Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Sodium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Discipline Construction Project of Guangdong Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC), the most common RCC subtype, displays significant intratumoral heterogeneity driven by metabolic reprogramming, which complicates our understanding of disease progression and limits treatment efficacy. This study aimed to construct a comprehensive cellular and transcriptional landscape of ccRCC, with emphasis on gene expression dynamics during malignant progression. An integrated analysis of 90 scRNA-seq samples comprising 534,227 cells revealed a progressive downregulation of sodium ion transport-related genes, particularly CHP1 (calcineurin B homologous protein isoform 1), which is predominantly expressed in epithelial cells. Reduced CHP1 expression was confirmed at both mRNA and protein levels using bulk RNA-seq, CPTAC proteomics, immunohistochemistry, and ccRCC cell lines. Survival analysis showed that high CHP1 expression correlated with improved prognosis. Functional analyses, including pseudotime trajectory, Mfuzz clustering, and cell–cell communication modeling, indicated that CHP1+ epithelial cells engage in immune interaction via PPIA–BSG signaling. Transcriptomic profiling and molecular docking suggested that CHP1 modulates amino acid transport through SLC38A1. ZNF460 was identified as a potential transcription factor of CHP1. Virtual screening identified arbutin and imatinib mesylate as candidate CHP1-targeting compounds. These findings establish CHP1 downregulation as a novel molecular feature of ccRCC progression and support its utility as a prognostic biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsSodiumHumansDown-RegulationGene Expression Regulation, NeoplasticDisease ProgressionCell Line, TumorMolecular Docking SimulationPrognosisImatinib MesylateProteomicsMultiomics

Stichwörter der Autor:innen

calcineurin B homologous protein isoform 1clear cell renal cell carcinomaprognostic biomarkersingle-cell RNA sequencingsodium transporttumor microenvironment

Substanzen

SodiumImatinib Mesylate

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, China.
  • School of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
  • Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China.
  • Dongguan Key Laboratory of Public Health Laboratory Science, School of Public Health, Guangdong Medical University, Dongguan 523808, China.

ORCID-Profile: Ri-Ting Zhu, Jin-Cheng Zeng, Cui-Fang Han

Förderung

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Discipline Construction Project of Guangdong Medical University

Zitieren

APA

Wu, Y., Zhu, R. T., Chen, J. R., Liu, X. M., Huang, G. L., Zeng, J. C., Yu, H. B., Liu, X., & Han, C. F. (2025). Targeting Sodium Transport Reveals CHP1 Downregulation as a Novel Molecular Feature of Malignant Progression in Clear Cell Renal Cell Carcinoma: Insights from Integrated Multi-Omics Analyses. Biomolecules. https://doi.org/10.3390/biom15071019

Vancouver

Wu Y, Zhu RT, Chen JR, Liu XM, Huang GL, Zeng JC, et al. Targeting Sodium Transport Reveals CHP1 Downregulation as a Novel Molecular Feature of Malignant Progression in Clear Cell Renal Cell Carcinoma: Insights from Integrated Multi-Omics Analyses. Biomolecules. 2025. doi:10.3390/biom15071019

BibTeX
@article{Wu2025,
  author = {Wu, Yun and Zhu, Ri-Ting and Chen, Jia-Ru and Liu, Xiao-Min and Huang, Guo-Liang and Zeng, Jin-Cheng and Yu, Hong-Bing and Liu, Xin and Han, Cui-Fang},
  title = {Targeting Sodium Transport Reveals CHP1 Downregulation as a Novel Molecular Feature of Malignant Progression in Clear Cell Renal Cell Carcinoma: Insights from Integrated Multi-Omics Analyses},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15071019}
}
Kostenlos starten →